Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
102.02
-6.50 (-5.99%)
At close: Dec 5, 2025, 4:00 PM EST
101.99
-0.03 (-0.03%)
After-hours: Dec 5, 2025, 7:55 PM EST
Guardant Health Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$446,595
Profits / Employee
-$197,323
Market Cap
13.14B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GH News
- 20 hours ago - Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium - Business Wire
- 3 days ago - Senator Buys Coca-Cola, Hershey's Stock After Selling Magnificent Seven Stocks In 2025 - Benzinga
- 7 days ago - 5 Top Stocks For AI Fatigue - Seeking Alpha
- 15 days ago - These 15 stocks are still showing momentum — and a market-beating edge - Market Watch
- 17 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 23 days ago - Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access - Business Wire
- 25 days ago - Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring - Business Wire
- 4 weeks ago - Guardant Health to Participate in Upcoming Investor Conferences - Business Wire